Search details
1.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 384(17): 1601-1612, 2021 04 29.
Article
in English
| MEDLINE | ID: mdl-33913638
2.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med
; 384(17): 1589-1600, 2021 04 29.
Article
in English
| MEDLINE | ID: mdl-33913637
3.
Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
BMC Nephrol
; 23(1): 59, 2022 02 08.
Article
in English
| MEDLINE | ID: mdl-35135481
4.
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.
J Ren Nutr
; 32(4): e1-e14, 2022 07.
Article
in English
| MEDLINE | ID: mdl-34364782
5.
Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 78(5): 709-718, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34332007
6.
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
Nephrol Dial Transplant
; 36(1): 137-150, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32030422
7.
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials.
Nephrol Dial Transplant
; 36(5): 871-883, 2021 04 26.
Article
in English
| MEDLINE | ID: mdl-32588050
8.
Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.
BMC Nephrol
; 21(1): 88, 2020 03 07.
Article
in English
| MEDLINE | ID: mdl-32143582
9.
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
J Am Soc Nephrol
; 30(9): 1723-1733, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31201218
10.
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Kidney Int
; 96(4): 1030-1036, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31377056
11.
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.
Am J Nephrol
; 50(6): 473-480, 2019.
Article
in English
| MEDLINE | ID: mdl-31658466
12.
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Nephrol Dial Transplant
; 34(7): 1163-1170, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-29846719
13.
Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.
Am J Kidney Dis
; 71(3): 423-435, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29336855
14.
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
Nephrol Dial Transplant
; 32(11): 1918-1926, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28339993
15.
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
Kidney Int
; 90(5): 1115-1122, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27650732
16.
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
N Engl J Med
; 368(4): 320-32, 2013 Jan 24.
Article
in English
| MEDLINE | ID: mdl-23343062
17.
Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled Trials.
Nephrol Dial Transplant
; 36(6): 1139, 2021 May 27.
Article
in English
| MEDLINE | ID: mdl-33263750
18.
Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
Curr Hypertens Rep
; 18(3): 23, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26894597
19.
Novel Agents for the Prevention and Management of Hyperkalemia.
Rev Cardiovasc Med
; 16(2): 140-55, 2015.
Article
in English
| MEDLINE | ID: mdl-26198561
20.
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Nephrol Dial Transplant
; 30(6): 1037-46, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25691681